Friday, December 22, 2023 11:43:56 AM
Well, there's the few % I was thinking of but why get off here? There's no sign of the drift up stopping...
https://stockcharts.com/h-sc/ui?s=ALXO
https://finance.yahoo.com/news/alx-oncology-holdings-inc-alxo-214706863.html
Jefferies Upgrades ALX Oncology Holdings to Buy, Raises Price Target to $18
BENZINGA 6:27 AM ET Dec-08-2023
Jefferies analyst Michael Yee upgrades ALX Oncology Holdings (ALXO.NaE) from Hold to Buy and raises the price target from $8 to $18.
Form SC 13D/A ALX ONCOLOGY HOLDINGS Filed by: LSV Associates, LLC
10K WIZARD
6:00 AM ET Dec-20-2023
http://archive.fast-edgar.com/20231220/AHBYD22D8M2232ZZ272F2WZZHEUJZ2Z2Z252
Filed on: December 20, 2023
Refinitiv/Verus upgrades ALX ONCOLOGY HOLDINGS ORD SHS from SELL to HOLD.
INVESTARS ANALYST ACTIONS - PUBLIC - 1:13 PM ET Nov-27-2023
On November 27, 2023 Refinitiv/Verus upgraded ALX ONCOLOGY HOLDINGS ORD SHS from SELL to HOLD.
Recent ALXO News
- ALX Oncology Appoints Allison Dillon as Chief Business Officer • GlobeNewswire Inc. • 05/07/2024 01:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/06/2024 08:02:18 PM
- ALX Oncology Announces Initiation of Phase 2 Investigator-Sponsored Trial of Neoadjuvant Radiation and Evorpacept in Combination with Pembrolizumab in Patients with Untreated HPV-Mediated Oropharyngeal Cancer • GlobeNewswire Inc. • 04/30/2024 01:00:00 PM
- ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual Meeting • GlobeNewswire Inc. • 04/24/2024 02:00:00 PM
- ALX Oncology Reports Encouraging Clinical Data of Evorpacept in Combination with Standard-of-Care in an Ongoing Phase 1/2 Clinical Trial in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (“R/R B-NHL”) • GlobeNewswire Inc. • 04/09/2024 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:05:18 PM
- ALX Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/07/2024 09:03:00 PM
- ALX Oncology Announces Two Evorpacept Clinical Abstracts Accepted for Presentation at the AACR Annual Meeting • GlobeNewswire Inc. • 03/05/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 11:24:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 11:17:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 11:09:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:03:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:28:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:25:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:17:04 PM
- ALX Oncology to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/03/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:01:08 PM
- ALX Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/13/2023 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:03:09 PM
- ALX Oncology Announces November Investor Conference Participation • GlobeNewswire Inc. • 11/01/2023 08:05:00 PM
- ALX Oncology Announces Closing of Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares • GlobeNewswire Inc. • 10/10/2023 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 10:06:59 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/06/2023 10:05:09 AM
- ALX Oncology Announces Pricing of Public Offering • GlobeNewswire Inc. • 10/05/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 09:21:58 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM